Targeting the membrane-proximal C2-set domain of CD33 for improved CAR T cell therapySalvatore Fiorenza(The University of Sydney), Roland B. Walter(University of Washington)Molecular Therapy OncologyJuly 31, 202410.1016/j.omton.2024.200854Cited by 9SaveCiteExport RISWatch citationsRelated PapersMinimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis|Haematologica|2017|282